The Precision Medicine in Nephrology Research Program (PMNP) is comprised of researchers and clinicians at the Snyder Institute, Cumming School of Medicine, University of Calgary who share common interests in understanding the molecular and genetic mechanisms of kidney disease to define disease specific biomarkers, develop advanced diagnostic testing and targeted treatments for patients with kidney disease.
Ultimately, our work is focused on producing novel evidence and data to support the integration of personalized testing and treatment options, or precision medicine, into clinical care in nephrology.
We are working to achieve these goals through basic research projects, clinical research projects, and by establishing a population-based biospecimen collection. Biobank for the Molecular Classification of Kidney Disease (BMCKD) to translate knowledge to patients with kidney disease.
- Dr. Daniel Muruve
Professor, Biobank Director
- Dr. Justin Chun
Assistant Professor, Assistant Director
- Dr. Hallgrimur Benediktsson
Professor, Biobank Co-Director
- Dr. Graciela Andonegui
- Kevin Chapman
Biobank Facilities Manager, Calgary Lab Services
- Joyce Maloney
- Sheila Li
Research Project Coordinator
Biobank Management Committee: Dr. Daniel Muruve, Dr. Hallgrimur Benediktsson, Dr. Justin Chun, Dr. Leland Baskin, Dr. Pietro Ravani, Dr. Susan Samuel, Leah Nichols and Danielle Meister.